These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37017910)

  • 1. Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022.
    Abdelnour C; Gonzalez MC; Gibson LL; Poston KL; Ballard CG; Cummings JL; Aarsland D
    Neurol Ther; 2023 Jun; 12(3):727-749. PubMed ID: 37017910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for dementia with Lewy Bodies: a review of Phase II & III trials.
    Tolea MI; Ezzeddine R; Camacho S; Galvin JE
    Expert Opin Emerg Drugs; 2023 Dec; 28(3):167-180. PubMed ID: 37531299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical drug development for dementia with Lewy bodies: past and present.
    Lee G; Cummings J; Decourt B; Leverenz JB; Sabbagh MN
    Expert Opin Investig Drugs; 2019 Nov; 28(11):951-965. PubMed ID: 31614096
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in the pharmacotherapeutic management of dementia with Lewy bodies.
    Palermo G; Ceravolo R; Bonuccelli U
    Expert Opin Pharmacother; 2018 Oct; 19(15):1643-1653. PubMed ID: 30212224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological management of dementia with Lewy bodies with a focus on zonisamide for treating parkinsonism.
    Panza F; Lozupone M; Watling M; Imbimbo BP
    Expert Opin Pharmacother; 2021 Feb; 22(3):325-337. PubMed ID: 33021110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update.
    MacDonald S; Shah AS; Tousi B
    Drugs Aging; 2022 Jul; 39(7):505-522. PubMed ID: 35619045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in dementia with Lewy bodies.
    Armstrong MJ
    Ther Adv Neurol Disord; 2021; 14():17562864211057666. PubMed ID: 34840608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis.
    Donaghy PC; McKeith IG
    Alzheimers Res Ther; 2014; 6(4):46. PubMed ID: 25484925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers.
    Gibson LL; Abdelnour C; Chong J; Ballard C; Aarsland D
    Curr Opin Neurol; 2023 Aug; 36(4):264-275. PubMed ID: 37387459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic trials in dementia with Lewy bodies: a systematic review of the literature].
    Sacrez M; Lamothe M; Rauch L; Botzung A; Blanc F
    Geriatr Psychol Neuropsychiatr Vieil; 2021 Sep; 19(3):289-304. PubMed ID: 34609295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia with Lewy bodies: emerging drug targets and therapeutics.
    Pope ED; Cordes L; Shi J; Mari Z; Decourt B; Sabbagh MN
    Expert Opin Investig Drugs; 2021 Jun; 30(6):603-609. PubMed ID: 33899637
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic trials and Dementia with Lewy bodies: a systematic review of the literature.
    Sacrez M; Lamothe M; Rauch L; Botzung A; Blanc F
    Geriatr Psychol Neuropsychiatr Vieil; 2021 Dec; ():. PubMed ID: 34933841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodromal dementia with Lewy bodies.
    Donaghy PC; O'Brien JT; Thomas AJ
    Psychol Med; 2015 Jan; 45(2):259-68. PubMed ID: 25066469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lewy Body Dementia: An Overview of Promising Therapeutics.
    Skylar-Scott IA; Sha SJ
    Curr Neurol Neurosci Rep; 2023 Oct; 23(10):581-592. PubMed ID: 37572228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a core outcome set (COS) for Dementia with Lewy bodies (DLB).
    Grycuk E; Eichenholtz E; Aarsland D; Betzhold S; Daly G; Fitzpatrick R; Folkerts AK; Kalbe E; Kane JP; Kinchin I; Saldanha IJ; Smith V; Taylor JP; Thompson R; Leroi I
    HRB Open Res; 2022; 5():57. PubMed ID: 36619176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.